CLAYTON’S BASIC PHARMACOLOGY FOR
NURSES EXAM PREP 2026 TEST PAPER
QUESTIONS AND SOLUTIONS
◉ Brand Name. Answer: Name given by the drug manufacturer.
◉ Nonproprietary Name. Answer: Generic name provided by USAN
Council.
◉ United States Pharmacopoeia. Answer: Contains standards for
nutritional supplements.
◉ Drug Facts and Comparisons. Answer: Contains monographs for
all therapeutic class drugs.
◉ AHFS Drug Information. Answer: Monographs for nearly all
single-entity drugs.
◉ DailyMed. Answer: Comprehensive online resource for medicines.
◉ Drug Monographs. Answer: Detailed descriptions of drugs in a
class.
,◉ Natural Medicines Comprehensive Database. Answer: Evidence-
based info on herbal medicines.
◉ Drug Interaction Facts. Answer: Information on drug interactions.
◉ USP Dictionary of USAN. Answer: Compilation of drug names and
pronunciations.
◉ Martindale—The Complete Drug Reference. Answer:
Comprehensive drug reference for various medications.
◉ Nutritional Supplements. Answer: Products intended to
supplement diet.
◉ Clinical Judgment. Answer: Decision-making based on clinical
data.
◉ Patient Education. Answer: Information provided to patients
about medications.
◉ Cost Indices. Answer: Comparative pricing information for drugs.
,◉ Dosage Forms. Answer: Forms in which drugs are available.
◉ Therapeutic Uses. Answer: Approved and unapproved uses of
drugs.
◉ Healthcare Providers. Answer: Professionals who prescribe and
administer medications.
◉ Public Access. Answer: Availability of drug information to general
public.
◉ Safety. Answer: Considerations for preventing harm in drug use.
◉ Physiological Integrity. Answer: Maintaining bodily functions and
health.
◉ Federal Food, Drug, and Cosmetic Act. Answer: Legislation
authorizing FDA drug safety evaluation.
◉ Durham Humphrey Amendment. Answer: Defines prescription-
only drugs requiring medical supervision.
◉ Controlled Substances Act. Answer: Regulates controlled
substances and their categorization.
, ◉ Kefauver Harris Drug Amendment. Answer: Mandates drug
efficacy proof before marketing.
◉ Meperidine (Demerol). Answer: A Schedule II drug with high
abuse potential.
◉ Schedule I Drugs. Answer: High abuse potential, no medical use
recognized.
◉ Schedule II Drugs. Answer: High abuse potential, severe
dependence risk.
◉ Schedule III Drugs. Answer: Moderate abuse potential,
dependence risk exists.
◉ Schedule IV Drugs. Answer: Low abuse potential, limited
dependence risk.
◉ Fast Tracking. Answer: Expedited FDA process for urgent drug
approvals.
◉ Investigational New Drug Application. Answer: Application for
FDA approval of new drugs.
NURSES EXAM PREP 2026 TEST PAPER
QUESTIONS AND SOLUTIONS
◉ Brand Name. Answer: Name given by the drug manufacturer.
◉ Nonproprietary Name. Answer: Generic name provided by USAN
Council.
◉ United States Pharmacopoeia. Answer: Contains standards for
nutritional supplements.
◉ Drug Facts and Comparisons. Answer: Contains monographs for
all therapeutic class drugs.
◉ AHFS Drug Information. Answer: Monographs for nearly all
single-entity drugs.
◉ DailyMed. Answer: Comprehensive online resource for medicines.
◉ Drug Monographs. Answer: Detailed descriptions of drugs in a
class.
,◉ Natural Medicines Comprehensive Database. Answer: Evidence-
based info on herbal medicines.
◉ Drug Interaction Facts. Answer: Information on drug interactions.
◉ USP Dictionary of USAN. Answer: Compilation of drug names and
pronunciations.
◉ Martindale—The Complete Drug Reference. Answer:
Comprehensive drug reference for various medications.
◉ Nutritional Supplements. Answer: Products intended to
supplement diet.
◉ Clinical Judgment. Answer: Decision-making based on clinical
data.
◉ Patient Education. Answer: Information provided to patients
about medications.
◉ Cost Indices. Answer: Comparative pricing information for drugs.
,◉ Dosage Forms. Answer: Forms in which drugs are available.
◉ Therapeutic Uses. Answer: Approved and unapproved uses of
drugs.
◉ Healthcare Providers. Answer: Professionals who prescribe and
administer medications.
◉ Public Access. Answer: Availability of drug information to general
public.
◉ Safety. Answer: Considerations for preventing harm in drug use.
◉ Physiological Integrity. Answer: Maintaining bodily functions and
health.
◉ Federal Food, Drug, and Cosmetic Act. Answer: Legislation
authorizing FDA drug safety evaluation.
◉ Durham Humphrey Amendment. Answer: Defines prescription-
only drugs requiring medical supervision.
◉ Controlled Substances Act. Answer: Regulates controlled
substances and their categorization.
, ◉ Kefauver Harris Drug Amendment. Answer: Mandates drug
efficacy proof before marketing.
◉ Meperidine (Demerol). Answer: A Schedule II drug with high
abuse potential.
◉ Schedule I Drugs. Answer: High abuse potential, no medical use
recognized.
◉ Schedule II Drugs. Answer: High abuse potential, severe
dependence risk.
◉ Schedule III Drugs. Answer: Moderate abuse potential,
dependence risk exists.
◉ Schedule IV Drugs. Answer: Low abuse potential, limited
dependence risk.
◉ Fast Tracking. Answer: Expedited FDA process for urgent drug
approvals.
◉ Investigational New Drug Application. Answer: Application for
FDA approval of new drugs.
